Table 4 Follow-up and toxicity
From: MR-guided stereotactic body radiation therapy for primary cardiac sarcomas
| Patient 1 (LMU) | Patient 2 (LMU) | Patient 3 (LMU) | Patient 4 (A. Gemelli) | |
|---|---|---|---|---|
| Time from last RT to follow up (months) | 6 | 6 | 3 | 1 |
| Local control | Yes | Yes | n.a | Yes |
| Metastases | No | Yes, mediastinal lymphnode metastases, liver metastases | n.a | [Yes, from melanoma] |
| Toxicity at first follow-up |
Fatigue CTCAE °1 Dyspnea CTCAE °1 |
Fatigue CTCAE °2 Dyspnea CTCAE °2 Chest pain CTCAE °1 | None |
Fatigue CTCAE °2 Dyspnea CTCAE °2 |